Cary Street Partners Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Cary Street Partners Asset Management's MDT Position: Q3 2024 in Review
Cary Street Partners Asset Management increased its Medtronic (MDT) stake by 0.68% in Q3 2024, buying an estimated $15.3K and bringing the position to 26,970 shares worth $2.43M. The position accounts for 0.32% of the portfolio, ranked #80.
Cary Street Partners Asset Management first reported a position in MDT in Q4 2020 and has held it in 16 quarters since. The position peaked at $2.6M in Q1 2022. 2,064 funds tracked by Wall St. Rank hold MDT as of Q3 2024.
- Cary Street Partners Asset Management held 26,970 shares of Medtronic worth $2.43M as of Q3 2024.
- Cary Street Partners Asset Management bought 182 Medtronic shares in Q3 2024, an estimated $15.3K.
- Medtronic made up 0.32% of Cary Street Partners Asset Management's portfolio in Q3 2024, its #80 holding.
- Cary Street Partners Asset Management first reported a position in Medtronic in Q4 2020 and has held it in 16 quarters since.
- Cary Street Partners Asset Management's Medtronic position peaked at $2.6M in Q1 2022.
- 2,064 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.
Based on Cary Street Partners Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.